Rossari Biotech Limited
NSE:ROSSARI.NS
817.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,983.51 | 4,896.5 | 4,727.15 | 4,637.69 | 4,834.68 | 4,106.06 | 4,064.66 | 3,892.69 | 4,254.36 | 4,347.1 | 4,311.34 | 4,284.16 | 3,845.16 | 2,311.1 | 2,162.85 | 2,099.83 | 1,716.74 | 1,094.66 | 1,576.28 | 1,624.04 | 1,503.32 | 1,278.1 |
| Cost of Revenue
| 3,407 | 3,848.57 | 3,793.88 | 3,229.79 | 3,427.64 | 3,281.46 | 2,862.68 | 2,723.92 | 3,017.54 | 3,106.07 | 3,301.47 | 3,215.69 | 2,993.04 | 1,597.65 | 1,670.7 | 1,397.87 | 1,080.45 | 637.52 | 1,082.54 | 1,028.96 | 892.99 | 806.26 |
| Gross Profit
| 1,576.51 | 1,047.93 | 933.27 | 1,407.9 | 1,407.04 | 824.6 | 1,201.98 | 1,168.77 | 1,236.82 | 1,241.03 | 1,009.87 | 1,068.47 | 852.12 | 713.45 | 492.15 | 701.96 | 636.29 | 457.14 | 493.74 | 595.08 | 610.33 | 471.84 |
| Gross Profit Ratio
| 0.316 | 0.214 | 0.197 | 0.304 | 0.291 | 0.201 | 0.296 | 0.3 | 0.291 | 0.285 | 0.234 | 0.249 | 0.222 | 0.309 | 0.228 | 0.334 | 0.371 | 0.418 | 0.313 | 0.366 | 0.406 | 0.369 |
| Reseach & Development Expenses
| 0 | 0 | 70.17 | 0 | 0 | 0 | 82.55 | 0 | 0 | 0 | 59.53 | 0 | 0 | 0 | 75.01 | 0 | 0 | 0 | 53.53 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 591.44 | 552.79 | 458.08 | 510.8 | 496.1 | 388.28 | 302.89 | 385.34 | 429.97 | 428.48 | 278.2 | 201.8 | 139.6 | 226.43 | 152.53 | 108.51 | 121.74 | 73.57 | 118.69 | 101.44 | 95.32 | 80.09 |
| Other Expenses
| 1,068.69 | 9.48 | 3.9 | 35.02 | 13.64 | 21.9 | 28.06 | 11.14 | 8.2 | 816.94 | -75.72 | 63.56 | 39.62 | 30.71 | -46.07 | 7.57 | 39.51 | 15.99 | -16.17 | 0.63 | 8.43 | 0 |
| Operating Expenses
| 1,068.69 | 552.79 | 458.08 | 922.08 | 922.51 | 388.28 | 816.32 | 786.71 | 827.7 | 816.94 | 642.54 | 779.23 | 514.98 | 405.44 | 213.79 | 422.15 | 391.27 | 257.96 | 297.87 | 337.95 | 369.8 | 276.73 |
| Operating Income
| 507.82 | 495.14 | 475.19 | 521.04 | 498.37 | 436.32 | 301.05 | 393.39 | 418.47 | 437.71 | 357.93 | 289.24 | 337.14 | 308.01 | 278.36 | 279.81 | 245.02 | 199.18 | 195.87 | 257.13 | 240.53 | 187.3 |
| Operating Income Ratio
| 0.102 | 0.101 | 0.101 | 0.112 | 0.103 | 0.106 | 0.074 | 0.101 | 0.098 | 0.101 | 0.083 | 0.068 | 0.088 | 0.133 | 0.129 | 0.133 | 0.143 | 0.182 | 0.124 | 0.158 | 0.16 | 0.147 |
| Total Other Income Expenses Net
| -26.72 | -27.37 | -21.34 | -43.23 | -50.29 | -41.26 | 71.26 | -46.68 | -82.25 | -50.76 | -5.14 | 30.23 | 20.97 | 24.37 | 20.71 | 3.95 | 32.84 | 8.51 | 8.54 | -10.47 | -3.7 | 3.21 |
| Income Before Tax
| 481.1 | 467.77 | 453.85 | 477.81 | 448.08 | 395.06 | 372.31 | 346.71 | 336.22 | 386.95 | 352.79 | 319.47 | 358.11 | 332.38 | 299.07 | 283.76 | 277.86 | 207.69 | 204.41 | 246.66 | 236.83 | 190.51 |
| Income Before Tax Ratio
| 0.097 | 0.096 | 0.096 | 0.103 | 0.093 | 0.096 | 0.092 | 0.089 | 0.079 | 0.089 | 0.082 | 0.075 | 0.093 | 0.144 | 0.138 | 0.135 | 0.162 | 0.19 | 0.13 | 0.152 | 0.158 | 0.149 |
| Income Tax Expense
| 127.77 | 120.88 | 114.37 | 133.91 | 118.6 | 102.38 | 82.52 | 89.9 | 97.06 | 100.14 | 108.95 | 94.08 | 95.82 | 86.95 | 77.02 | 67.57 | 70.58 | 52.75 | 53.42 | 64.12 | 59.47 | 48.87 |
| Net Income
| 353.33 | 348.99 | 341.32 | 343.9 | 329.48 | 292.19 | 289.79 | 256.81 | 239.16 | 286.81 | 243.84 | 225.39 | 262.29 | 245.22 | 224.27 | 216.01 | 206.98 | 154.94 | 150.99 | 182.54 | 177.36 | 141.64 |
| Net Income Ratio
| 0.071 | 0.071 | 0.072 | 0.074 | 0.068 | 0.071 | 0.071 | 0.066 | 0.056 | 0.066 | 0.057 | 0.053 | 0.068 | 0.106 | 0.104 | 0.103 | 0.121 | 0.142 | 0.096 | 0.112 | 0.118 | 0.111 |
| EPS
| 6.39 | 6.32 | 6.18 | 6.23 | 5.97 | 5.3 | 5.25 | 4.66 | 4.34 | 5.21 | 4.44 | 4.09 | 4.77 | 4.52 | 4.32 | 4.16 | 3.99 | 2.98 | 3.11 | 3.75 | 3.65 | 2.93 |
| EPS Diluted
| 6.38 | 6.32 | 6.17 | 6.21 | 5.95 | 5.28 | 5.24 | 4.63 | 4.32 | 5.18 | 4.41 | 4.07 | 4.74 | 4.49 | 4.32 | 4.11 | 3.99 | 2.98 | 3.11 | 3.7 | 3.6 | 2.93 |
| EBITDA
| 669.53 | 648.86 | 635.93 | 671.92 | 649.51 | 577.46 | 575.92 | 552.97 | 574.8 | 590.96 | 556.1 | 532.56 | 479.29 | 401.91 | 380.97 | 348.03 | 340.28 | 257.31 | 260.53 | 299.47 | 291.59 | 217.698 |
| EBITDA Ratio
| 0.134 | 0.133 | 0.135 | 0.145 | 0.134 | 0.141 | 0.142 | 0.142 | 0.135 | 0.136 | 0.129 | 0.124 | 0.125 | 0.174 | 0.176 | 0.166 | 0.198 | 0.235 | 0.165 | 0.184 | 0.194 | 0.17 |